Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Mokari Atabak. Officer active across 1 company, notably CORCEPT THERAPEUTICS INC. Aggregated, 43 filings have been recorded. Split: 0 buy · 22 sells. Total volume traded: €13.5m. History available since 1 September 2022. The latest transaction was filed on 30 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Mokari Atabak
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Mokari Atabak is Chief Financial Officer at CORCEPT THERAPEUTICS INC. He has 29 filings in total, and in the sampled recent filings from 2022-09-06 to 2026-07-17, sales amount to EUR 5477739 and the modal transaction nature is Attribution.